Purchases and Sales Made in Q1 2022 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q1 2022. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 12, 2022
Q1 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-25.4K- 56.26% |
$703K - $1M
|
19.8K
$444K
|
|
May 13, 2022
Q1 2022
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-49K- 48.15% |
$1.35M - $1.93M
|
52.8K
$1.19M
|
|
May 16, 2022
Q1 2022
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-50K- 14.29% |
$1.38M - $1.97M
|
300K
$6.74M
|
|
May 16, 2022
Q1 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-52.6K- 30.1% |
$1.45M - $2.07M
|
122K
$2.75M
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-54.2K- 1.75% |
$1.5M - $2.13M
|
3.05M
$68.5M
|
|
May 12, 2022
Q1 2022
|
Citigroup Inc
|
SELL
|
- |
-55.5K- 46.64% |
$1.53M - $2.18M
|
63.5K
$1.43M
|
|
May 16, 2022
Q1 2022
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-60K- 47.62% |
$1.66M - $2.36M
|
66K
$1.48M
|
|
May 11, 2022
Q1 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-92.9K- 72.71% |
$2.57M - $3.65M
|
34.9K
$784K
|
|
May 16, 2022
Q1 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-100KClosed |
$2.76M - $3.93M
|
0
$0
|
|
May 13, 2022
Q1 2022
|
Candriam S.C.A.
|
SELL
|
- |
-110K- 28.34% |
$3.03M - $4.31M
|
277K
$6.23M
|
|
May 16, 2022
Q1 2022
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-119K- 5.51% |
$3.3M - $4.69M
|
2.05M
$46M
|
|
May 16, 2022
Q1 2022
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-133KClosed |
$3.68M - $5.23M
|
0
$0
|
|
Nov 08, 2023
Q1 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-149K- 19.0% |
$4.13M - $5.87M
|
636K
$14.3M
|
|
May 16, 2022
Q1 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-167KClosed |
$4.61M - $6.56M
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-190K- 91.27% |
$5.24M - $7.45M
|
18.1K
$407K
|
|
May 16, 2022
Q1 2022
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-223K- 43.3% |
$6.17M - $8.78M
|
292K
$6.57M
|
|
May 16, 2022
Q1 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-230KClosed |
$6.35M - $9.04M
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-272KClosed |
$7.51M - $10.7M
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-346K- 68.97% |
$9.57M - $13.6M
|
156K
$3.5M
|
|
May 16, 2022
Q1 2022
|
Cowen And Company, LLC
|
SELL
|
- |
-467KClosed |
$12.9M - $18.3M
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-649K- 76.84% |
$17.9M - $25.5M
|
196K
$4.39M
|
|
May 16, 2022
Q1 2022
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-837K- 21.35% |
$23.1M - $32.9M
|
3.08M
$69.3M
|